Suppr超能文献

变应原交叉反应性的系统评价:将基本概念转化为临床相关性

A systematic review of allergen cross-reactivity: Translating basic concepts into clinical relevance.

作者信息

Sharma Ekansh, Vitte Joana

机构信息

Thermo Fisher Scientific, Uppsala, Sweden.

Aix-Marseille University, MEPHI, IHU Méditerranée Infection, Marseille, France.

出版信息

J Allergy Clin Immunol Glob. 2024 Feb 19;3(2):100230. doi: 10.1016/j.jacig.2024.100230. eCollection 2024 May.

Abstract

Access to the molecular culprits of allergic reactions allows for the leveraging of molecular allergology as a new precision medicine approach-one built on interdisciplinary, basic, and clinical knowledge. Molecular allergology relies on the use of allergen molecules as tools for the diagnosis and management of allergic patients. It complements the conventional approach based on skin and allergen extract testing. Major applications of molecular allergology comprise accurate identification of the offending allergen thanks to discrimination between genuine sensitization and allergen cross-reactivity, evaluation of potential severity, patient-tailored choice of the adequate allergen immunotherapy, and prediction of its expected efficacy and safety. Allergen cross-reactivity, defined as the recognition of 2 or more allergen molecules by antibodies or T cells of the same specificity, frequently interferes with allergen extract testing. At the mechanistic level, allergen cross-reactivity depends on the allergen, the host's immune response, and the context of their interaction. The multiplicity of allergen molecules and families adds further difficulty. Understanding allergen cross-reactivity at the immunologic level and translating it into a daily tool for the management of allergic patients is further complicated by the ever-increasing number of characterized allergenic molecules, the lack of dedicated resources, and the need for a personalized, patient-centered approach. Conversely, knowledge sharing paves the way for improved clinical use, innovative diagnostic tools, and further interdisciplinary research. Here, we aimed to provide a comprehensive and unbiased state-of-the art systematic review on allergen cross-reactivity. To optimize learning, we enhanced the review with basic, translational, and clinical definitions, clinical vignettes, and an overview of online allergen databases.

摘要

了解过敏反应的分子元凶,有助于将分子变应性学作为一种新的精准医学方法加以利用,这种方法建立在跨学科、基础和临床知识之上。分子变应性学依赖于使用过敏原分子作为诊断和管理过敏患者的工具。它补充了基于皮肤和过敏原提取物检测的传统方法。分子变应性学的主要应用包括:由于能够区分真正的致敏和过敏原交叉反应,从而准确识别致病过敏原;评估潜在严重程度;根据患者情况选择合适的过敏原免疫疗法;预测其预期疗效和安全性。过敏原交叉反应被定义为具有相同特异性的抗体或T细胞对两种或更多种过敏原分子的识别,它经常干扰过敏原提取物检测。在机制层面,过敏原交叉反应取决于过敏原、宿主的免疫反应及其相互作用的背景。过敏原分子和家族的多样性增加了进一步的困难。随着已鉴定的过敏原分子数量不断增加、缺乏专门资源以及需要个性化的、以患者为中心的方法,在免疫水平上理解过敏原交叉反应并将其转化为过敏患者管理的日常工具变得更加复杂。相反,知识共享为改善临床应用、创新诊断工具和进一步的跨学科研究铺平了道路。在此,我们旨在提供一篇关于过敏原交叉反应的全面且无偏见的最新系统综述。为了优化学习,我们用基础、转化和临床定义、临床案例以及在线过敏原数据库概述对该综述进行了补充。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f52a/10959674/85753247fd2f/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验